A blocking peptide containing 16 amino acids near the carboxy terminus of human BAFF.
Points forts
Source
Synthetic
(Accession #: NP_006564) The BAFF/BLyS/TNFSF13B Blocking Peptide has been validated for the following applications: Antibody Competition.
Caractéristiques techniques
| Marque | Novus Biologicals |
|---|
| Réf. B-LABO | BL-RE-054475 |
|---|
| Réf. fabricant | 18289135 |
|---|
| Gene ID (Entrez) | 10673 |
|---|
| Espèces | Human |
|---|
| Contenu et stockage | Store at -20 C. Avoid freeze-thaw cycles. |
|---|
| Formule | PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin. |
|---|
| À utiliser avec (application) | This Peptide is Useful as a Blocking Peptide for NBP1-76843. For Further Blocking Peptide Related Protocol, Click Here . |
|---|
| Alias de gène | ApoL related ligand TALL-1, B lymphocyte stimulator, BAFFB-cell activating factor, B-cell-activating factor, BLyS, BLYSB-lymphocyte stimulator, CD257, CD257 antigen, Dendritic cell-derived TNF-like molecule, DTL, TALL-1 delta BAFF, TALL1Delta4 BAFF, THANK, TNF and ApoL-related leukocyte expressed ligand 1, TNF- and APOL-related leukocyte expressed ligand 1, TNF homolog that activates apoptosis, TNFSF20, tumor necrosis factor (ligand) superfamily, member 13 b, tumor necrosis factor (ligand) superfamily, member 20, tumor necrosis factor ligand superfamily member 13 B, tumor necrosis factor superfamily, member 13 b, tumor necrosis factor-like protein ZTNF4, ZTNF4 |
|---|
| Symbole de gène(s) | TNFSF13B |
|---|
| Type de produit | BAFF/BLyS/TNFSF13B |
|---|
| Quantité | 0.05 mg |
|---|
| État réglementaire | RUO - research use only |
|---|
| Source | Synthetic |
|---|
| Consigne | 16 amino acids near the carboxy terminus of human BAFF |
|---|
Une question, une configuration particulière ?
Contactez-nous pour un devis.
